Wikidata entity: Q65542179
Quantities
| P2899 | minimum age | 18 |
| P1132 | number of participants | 100 |
| P6099 | clinical trial phase | ... | Q42824827 (phase III clinical trial) | phase III clinical trial |
| P17 | country | ... | Q30 (United States) | United States |
| P582 | end time | ... | 2004-11-01 | ??? |
| P31 | instance of | ... | Q30612 (clinical trial) | clinical trial |
| P1050 | medical condition | ... | Q844935 (coronary artery disease) | coronary artery disease |
| P4844 | research intervention | ... | Q32089 (sirolimus) | sirolimus |
| P6153 | research site | ... | Q6523170 (Lenox Hill Hospital) | Lenox Hill Hospital |
| P580 | start time | ... | 2003-09-01 | ??? |
| P8363 | study type | ... | Q78089383 (interventional study) | interventional study |
| P1476 | title | Monolingualtext | A Multicenter, Non-Randomized Study of the 2.25mm Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in the Treatment of Patients With de Novo Native Coronary Artery Lesions | ??? |
| P3098 | ClinicalTrials.gov ID | NCT00232739 |
Why not click here or view trends?
log id: 5791757